Begin with the product you can actually budget for
Ask the service to identify the proposed medication, formulation, supply duration and dispensing pharmacy. A cash quote for an approved branded product belongs beside another quote for that product. A compounded preparation requires a separate clinical and regulatory discussion. Compounded drugs are not FDA-approved, and price alone cannot establish that they are an appropriate alternative.
What the care fee buys
Ro and Hers publish a $39 first month and $149 recurring monthly care membership, with medication extra. These figures describe access to a service, not the cost of a month of treatment. Ask which appointments, messages and administrative work are included, whether tests add a charge and what you owe if no prescription follows the assessment.
How to read a no-membership offer
Amble and CoreAge advertise no separate membership fee. That simplifies one line of a quote, but the prescription still needs a price and supply period. Amble’s sitewide minimum spans services and is not a verified GLP-1 total. CoreAge’s conflicting $79 and $99 figures prevent a reliable cost ranking. Request a written renewal total before deciding either is cheaper.
Leave savings offers out until confirmed
Manufacturer or pharmacy offers can have eligibility conditions, product restrictions and expiration dates. Ask the dispensing pharmacy what you would pay under the offer and without it. Do not treat a conditional saving as assured income in your budget. Keep enrollment cash, renewal cost and any prepaid balance separately, then use the planner only when all required amounts are known.
How we compare
Care Daybook interprets public service information. We have not enrolled as patients or measured clinical quality. Treatment, availability and price depend on individual circumstances. Unknown totals stay unknown.
Our editorial approach · Commercial disclosureSources & offer details
Ro official treatment informationFDA Foundayo approvalHers official offeringAmble official treatment informationAmble program overviewFDA: concerns with unapproved GLP-1 drugsCoreAge Rx official treatment informationCoreAge program overviewConfirm current written terms directly. Compounded drugs are not FDA-approved.